ImmuCell Corp. has been granted final product approval fromthe U.S. Department of Agriculture for First Defense, anantibody-based treatment to prevent calf's scours, or diarrhea.
First Defense is a preventative against scours caused by bothE. coli and coronavirus bacteria. It is administered in capsuleform.
The product will be distributed in the United States by the endof the month, the company said. Sales in the United Kingdomand Ireland will begin through Rhone-Merieux Animal Healthunder distribution agreements with ImmuCell (NASDAQ:ICCC)of Portland, Maine.
ImmuCell estimates the U.S. market at about $4 million at thewholesale level.
(c) 1997 American Health Consultants. All rights reserved.